108866-54-2

Upstream product

• 108796-58-3 benzyl (1R,6S)-6-{[(benzyloxy)carbonyl]amino}-3-cyclohexen-1-ylcarbamate 
• 99938-59-7 bis(phenylmethyl) (1α,2β-cyclohexanediyl)bis(carbamate) 
• 108796-60-7 ((3R,4S)-4-Benzyloxycarbonylamino-7-oxa-bicyclo[4.1.0]hept-3-yl)-carbamic acid benzyl ester 
• 108796-60-7 bis(phenylmethyl) (1α,3α,4β,6α)-7-oxabicyclo<4.1.0>heptane-3,4-diylbis(carbamate) 
• 108796-62-9 bis(phenylmethyl) (1α,2β,4α,5α)-(4-(acetyloxy)-5-hydroxy-1,2-cyclohexanediyl)bis(carbamate) 
• 108796-62-9 Acetic acid (1S,2S,4R,5R)-4,5-bis-benzyloxycarbonylamino-2-hydroxy-cyclohexyl ester 
• 108796-64-1 bis(phenylmethyl) (1α,2β,4β)-(4-(acetyloxy)-5-oxo-1,2-cyclohexanediyl)bis(carbamate) 
• 108796-59-4 bis(phenylmethyl) (1α,2β,4α,5α)-(4,5-dihydroxy-1,2-cyclohexanediyl)bis(carbamate) 
• 108796-63-0 bis(phenylmethyl) (1α,2β,4β,5α)-(4,5-bis(acetyloxy)-1,2-cyclohexanediyl)bis(carbamate) 

Downstream Products

• 135619-10-2 (3aα,5β,6β,7aα)-bis(phenylmethyl) (hexahydro-2,2-dimethyl-1,3-benzodioxole-5,6-diyl)bis(carbamate) 
• 135619-10-2 (3aα,5β,6α,7aβ)-bis(phenylmethyl) (hexahydro-2,2-dimethyl-1,3-benzodioxole-5,6-diyl)bis(carbamate) 
• 135619-10-2 (3aα,5α,6β,7aα)-bis(phenylmethyl) (hexahydro-2,2-dimethyl-1,3-benzodioxole-5,6-diyl)bis(carbamate) 
• 108796-59-4 bis(phenylmethyl) (1α,2β,4β,5α)-(4,5-dihydroxy-1,2-cyclohexanediyl)bis(carbamate) 
• 108796-64-1 bis(phenylmethyl) (1α,2β,4β)-(4-(acetyloxy)-5-oxo-1,2-cyclohexanediyl)bis(carbamate) 
• 105415-84-7 (1R,2R,4S,5S)-4,5-Diamino-cyclohexane-1,2-diol 
• 108796-62-9 Acetic acid (1S,2S,4R,5R)-4,5-bis-benzyloxycarbonylamino-2-hydroxy-cyclohexyl ester 
• 108796-63-0 bis(phenylmethyl) (1α,2β,4β,5α)-(4,5-bis(acetyloxy)-1,2-cyclohexanediyl)bis(carbamate) 
• 108796-63-0 bis(phenylmethyl) (1α,2β,4α,5α)-(4,5-bis(acetyloxy)-1,2-cyclohexanediyl)bis(carbamate) 
• 135619-10-2 (3aα,5α,6β,7aβ)-bis(phenylmethyl) (hexahydro-2,2-dimethyl-1,3-benzodioxole-5,6-diyl)bis(carbamate) 
• 135619-10-2 (3aα,5α,6α,7aβ)-bis(phenylmethyl) (hexahydro-2,2-dimethyl-1,3-benzodioxole-5,6-diyl)bis(carbamate) 
• 105415-84-7 (1R,2R,4R,5S)-4,5-Diamino-cyclohexane-1,2-diol 
• 135100-57-1 (1α,2β,4α,5β)-4,4'-(4,5-dihydroxy-1,2-cyclohexanediyl)bis(2,6-piperazinedione) 
• 105415-84-7 (1R,2R,4R,5R)-4,5-Diamino-cyclohexane-1,2-diol 

Relevant academic research and scientific papers

Noncovalent secondary interactions in Co(II)salen complexes: O2 binding and catalytic activity in cyclohexene oxygenation

The O2 affinity of Co(II)Salen complexes 1-4 and their reactivity in cyclohexene oxygenation reactions of Co(II)Salen complexes 1-4 are modulated by noncovalent interactions such as hydrogen bonding and steric hindrance using a functionalized diamino bridge. Higher O2 affinity is observed in the case of efficient hydrogen-bonding interactions (complex 1), while increased steric hindrance (cis vs trans diamino bridge) around the Co-coordinated O2 is influencing the reactivity of the complexes.

Stereocontrolled Syntheses for the Six Diastereomeric 1,2-Dihydroxy-4,5-diaminocyclohexanes: PtII Complexes and P-388 Antitumor Properties

Stereocontrolled syntheses for the six diastereomeric 1,2-dihydroxy-4,5-diaminocyclohexanes 3a-f from cyclohexene diamines cis-4 and trans-5 are described.Cbz-protected species cis-9 and trans-11, respectively, served as a source of stable Cbz-protected p